Author: R. Ghanavati, MD
-
-
Daily Cardiology Symposium 1403: Antithrombotics in Preventive Cardiology
July 17, 2024DCS 1403: Antithrombotics
-
-
-
Daily Cardiology Symposium 1403: Cardiovascular Risk Modifiers
July 17, 2024DCS 1403: CVD Risk Modifiers
-
-
-
-
-
-
-
Save The Date: Hypertension and Hyperlipidemia Academy, No. 16
May 7, 2024Save The Date: 15th H&H Academy
-
-
-
-
-
-
Diabeat, 9th session: is Metformin still the champion for T2D and heart disease? a debate: Cons by Dr. Ghanavati
January 6, 2024Diabeat 9th session, case based discussion
-
-
-
-
AHA23 Congress Coverage: Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes: SELECT trial
November 18, 2023AHA23 Congress Coverage: Semaglutide in obesity and no DM (SELECT trial)
-
-
-
-
-
-
-
-
-
The Lost Puzzle In Diabetes Treatment: CAD and PAD in Patients with Diabetes
August 21, 2023CAD and PAD in DM
-
-
Daily Cardiology Symposium 1402 Day 2 Panel 4
July 25, 2023Infective Endocarditis and Prosthetic Valve Malfunction
-
-
Daily Cardiology Symposium 1402 Day 1 Panel 4
July 25, 2023Hypertension Crisis and Acute Hypertension in Pregnancy
-
Daily Cardiology Symposium 1402 Day 1 Panel 2
July 25, 2023Acute De Novo Heart Failure and Cardiogenic Shock
-
-
-
-
Vision: Adults with fasting TG=150-500mg with ACVD or DM
July 3, 2023Vision: Mild hypertriglyceridemia in moderate to high risk patients
-
-
Hypertension and Hyperlipidemia Academy: clinical tips for nurses and non-physician healthcare professionals
May 18, 2023H&H Academy: clinical tips for non-physicians
-
-
-
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
-
-
Vision: Adults with fasting TG=150-500mg without ACVD or DM
April 15, 2023Vision: Mild hypertriglyceridemia in low-risk patients
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
Hypertension and Hyperlipidemia Academy: Smoothing the path to cardiovascular risk reduction
February 15, 2023H&H Academy: CVD risk reduction
-
Vision: Vol. 3, Antithrombotic therapy for surgical bioprosthetic valves and valve repair
September 18, 2022Vision, 3rd episode: antithrombotic Tx. in bioprosthetic valves and valve repair
-
Save the date: Cardiorenal Metabolic Crossroads, 5th session
September 13, 2022Save the date: Cardiorenal Metabolic Crossroads, 5th session
-
Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%
September 13, 2022Umbrella: HF, Heart Failure with EF>40%
-
Umbrella: Heart Failure, Panel 2, Non-pharmacologic Approach to HF Management
September 13, 2022Umbrella: HF, Non-pharmacologic Approach to HF
-
-
Save the date: Case-based discussion in patients with diabetes
August 30, 2022Save the date: Case-based discussion in patients with diabetes
-
-
-
-
-
-
-
-
Pulse Wave Velocity, a marker for arterial stiffness and a risk modifier for ASCVD
August 24, 2022PWV in a nutshell
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
-
Save the date: Hypertension and Hyperlipidemia Academy No. 10
August 18, 2022Save the date: H&H Academy No. 10
-
-
-
Save the date: Pulse Wave Velocity, a marker for arterial stiffness and a risk modifier for ASCVD
August 3, 2022Save the date: Pulse Wave Velocity
-
-
-
Hypertension and Hyperlipidemia Academy, 10: for non-physician healthcare profesionals
July 19, 2022H&H Academy 10, for non-physician healthcare professionals
-
-
-
Save the date: 23rd case-based ECG interpretation workshop
June 30, 202223rd ECG workshop for medical and nursing trainees
-
Save the date: Hypertension and Hyperlipidemia Academy, No. 9
June 28, 2022Save the date: The 9th H&H Academy
-
-
-
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
Save the date: Hypertension and Hyperlipidemia Academy, 8th
May 10, 2022Save the date: 8th H&H Academy
-
Save the date: 22nd case-based ECG interpretation workshop
May 7, 202222nd ECG workshop for medical and nursing trainees
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
At a glance: Ticagrelor and prevention of recurrent thrombotic events in CCS
April 23, 2022Ticagrelor and secondary prevention in CCS
-
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
-
Umbrella: Hypertension, Challenges in the diagnosis & management of HTN
March 8, 2022Umbrella: HTN, diagnosis and management of HTN
-
Save the date: Hypertension and Hyperlipidemia Academy 7
March 3, 2022Save the date: the 7th H&H Academy session
-
HeartCast 5: practical approach to the treatment of HFrEF
February 23, 2022The fifth HeartCast: HFrEF management
-
-
-
-
-
HeartCast 4: practical approach to the treatment of HFrEF
February 9, 2022The fourth HeartCast: HFrEF management
-
-
-
-
which prophylaxis? for whom? VTE prophylaxis panel discussion
January 26, 2022Case-based panel discussion on VTE prophylaxis
-
Save the date: which prophylaxis? for whom? VTE prophylaxis panel discussion
January 19, 2022Case-based panel discussion on VTE prophylaxis
-
Hypertension and Hyperlipidemia Academy: for nurses and medical assistants
January 18, 2022H&H Academy: nurses and assistants
-
HeartCast 3: practical approach to the treatment of HFrEF
January 11, 2022The third HeartCast: HFrEF management
-
Hypertension and Hyperlipidemia Academy 5, a hybrid event
January 7, 20225th session of H&H Academy, online and onsite
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
At a Glance: Approach to Ticagrelor-induced Dyspnea
January 2, 2022Managing dyspnea induced by Ticagrelor
-
Umbrella Heart and Stroke: session 4, Antithrombotic therapy for the secondary prevention of stroke
January 2, 2022Umbrella H&S: session 4, secondary prevention of stroke
-
HeartCast 2: practical approach to the treatment of HFrEF
December 29, 2021The second HeartCast: HFrEF management
-
Save the date: 21st case-based ECG interpretation workshop
December 28, 202121st ECG workshop for medical and nursing trainees
-
-
-
At a glance: preventing cardiovascular thrombotic event after ACS
December 21, 2021Ticagrelor in preventing post-ACS thrombotic events
-
HeartCast 1: practical approach to the treatment of HFrEF
December 15, 2021The first HeartCast: HFrEF management
-
-
-
Save the date: Hypertension and hyperlipidemia academy, session 4
November 16, 2021The 4th session of Hypertension and hyperlipidemia academy
-
Save the date: Umbrella: Heart and Stroke
November 14, 2021The second program of Umbrella series: Heart and Stroke
-
Primary prevention in dyslipidemia as the only cardiovascular risk factor
November 4, 2021Dyslipidemia in primary prevention of low-risk patients
-
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
-
Save the date: 20th case-based ECG interpretation workshop
September 18, 202120th ECG workshop for medical and nursing trainees
-
-
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
September 17, 2021The role of Heparin in the management of thrombosis in COVID-19
-
-
-
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
August 24, 2021Neprilysin Inhibitors to prevent LV remodeling post MI
-
-
DiaBeat: The Beating Heart of Diabetes (7th session), a scientific debate
August 14, 20217th Diabetes Masterclass for Cardiologists
-
From optimal medical therapy to revascularization in CCS
August 14, 2021Choosing the best therapeutic strategy in CCS
-
Antithrombotic lighthouse, Cases and Faces: antithrombotic therapy in CAD
August 14, 2021Antithrombotic regimens in CAD
-
-
Save the date: Anti-thrombotic lighthouse: navigating a new path to CAD management
August 2, 2021Anti-thrombotic lighthouse, 3rd session: anti-thrombotic therapy in CAD Cardio Calendar
-
Save the date: Diabeat: 7th session, SGLT2 Inhibitors for Primary Prevention of CVD
August 1, 20217th diabeat masterclass for cardiologists: SGLT2i in CVD primary prevention
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
Tailored Antithrombotic therapy for CCS patients
July 25, 2021Best individual antithrombotic strategy in CCS
-
Save the date: 19th case-based ECG interpretation workshop
July 24, 202119th ECG workshop for medical and nursing trainees
-
Save the date: Anti-Thrombotic Lighthouse (2nd session)
July 14, 20212nd session of Anti-Thrombotic Lighthouse: antiplatelet therapy in CCS
-
Marking the antiplatelet therapy maze in ACS
July 12, 2021How to prevent atherosclerotic cardiovascular events
-
Safety and Efficacy of different antithrombotic strategies after TAVI
July 11, 2021Post-TAVI antithrombotic strategies
-
-
Save the date: Anti-Thrombotic Lighthouse (1st session)
June 26, 20211st session of Anti-Thrombotic Lighthouse: antiplatelet therapy in ACS
-
Cardiovascular complications of T2DM: the preventive role of SGLT2Is
June 20, 2021SGLT2Is and the prevention of cardiovascular complications in T2DM
-
DCS 1400: session 8, Valvular Heart disease
June 16, 2021The eighth panel of DCS 1400: Valvular Heart disease
-
-
-
DCS 1400: session 2, Diabetes for cardiologists
June 16, 2021The second panel of DCS 1400: diabetes for cardiologists
-
-
-
Left Atrial Appendage Occlusion to prevent Stroke
June 9, 2021Preventing Stroke by surgical LA Appendage Occlusion
-
How to reduce the atherosclerotic cardiovascular risk
May 18, 2021A case-based Review on HTN and DLP management
-
Updates on the management of Diabetes and cardiometabolic disease
May 18, 2021Actoverco Diabetes Lunch Webinar
-
Save the date: 18th ECG interpretation workshop
May 3, 2021A case-based online course for medical trainees
-
Save the date: Abidi Hypertension and Hyperlipidemia Academy
April 19, 2021Keeping up-to-date on HTN and DLP treatment
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
PCSK9 inhibitors place in patients with cardiometabolic diseases
March 16, 2021PCSK9 inhibitors from two perspectives of Endocrinologist & Cardiologist
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
Save the date: Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
October 20, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 4th Session – EAST-AFNET4 Trial
October 20, 2020Monthly Case-Based Clinical Problem Solving
-
At a glance; Place of FDC in CV outcomes
October 7, 2020Single-Pill Combination Therapy and CV Outcomes in HTN
-
Smoking and the Heart the Struggle Continues
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Ground-breaking research from ESC Congress 2020 (23)
September 16, 2020Part Twenty-three: Trial Review, ELDERCARE-AF
-
Ground-breaking research from ESC Congress 2020 (22)
September 16, 2020Part Twenty-Two: Trial Review, ATPCI
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (20)
September 16, 2020Part Twenty: Trial Review, POPULAR TAVI
-
Ground-breaking research from ESC Congress 2020 (19)
September 16, 2020Part Nineteen: Trial Review, EXPLORER-HCM
-
Ground-breaking research from ESC Congress 2020 (18)
September 16, 2020Part Eighteen: Trial Review, HOME-PE
-
Ground-breaking research from ESC Congress 2020 (17)
September 16, 2020Part Seventeen: Trial Review, REALITY
-
Ground-breaking research from ESC Congress 2020 (16)
September 16, 2020Part Sixteen: Trial Review, BPLTTC
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (14)
September 16, 2020Part Fourteen: Trial Review, POPULAR CABG
-
Ground-breaking research from ESC Congress 2020 (13)
September 16, 2020Part Thirteen: Trial Review, BAMI
-
Ground-breaking research from ESC Congress 2020 (12)
September 16, 2020Part Twelve: Trial Review, EVAPORATE
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (9)
September 16, 2020Part Nine: Trial Review, RATE-AF
-
Ground-breaking research from ESC Congress 2020 (8)
September 16, 2020Part Eight: Trial Review, COPS
-
Ground-breaking research from ESC Congress 2020 (7)
September 16, 2020Part Seven: Trial Review, COLCOT
-
Ground-breaking research from ESC Congress 2020 (6)
September 16, 2020Part Six: Trial Review, LoDoCo2
-
Ground-breaking research from ESC Congress 2020 (5)
September 16, 2020Part Five: Trial Review, EAST-AFNET4
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (3)
September 16, 2020Part Three: Trial Review; THEMIS, PAD
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
-
Daily Cardiology Journal Club: Second Session – ISCHEMIA Trial
August 27, 2020Monthly Case-Based Clinical Problem Solving
-
At a glance; FDC role in HTN Pharmacotherapy
August 9, 2020Fixed dose combination therapy in HTN Treatment
-
-
-
Daily Cardiology Journal Club: First Session – How to setup an effective Journal Club?
July 23, 2020Monthly Case-Based Clinical Problem Solving
-
-
At a glance; How dual pathway found its way into ESC guidelines?
June 7, 2020Rivaroxaban on board for CCS
-
-
Case Discussion (7)
May 29, 2020Approach to chest pain in a patient with a history of CCS in the era of COVID-19 pandemic
-
At a glance: ACEI and ARB in COVID-19 Era
March 19, 2020The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
-
Benefits of Targeting for a <70 mg/dL LDL Cholesterol During 5 Years After Ischemic Stroke
March 6, 2020The findings of TST study
-
Electrical versus pharmacological cardioversion for acute AF in emergency settings
March 6, 2020The findings of RAFF2 trial
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Intensive LDL lowering beyond current recommendations for MACE prevention
February 12, 2020A meta-analysis of RCTs
-
-
Association of Anticoagulation Therapy with the Risk of Fracture in AF Patients
January 21, 2020The findings of a recent study
-
Complete vs. Culprit-only Revascularization in Patients with STEMI and Multi-Vessel Coronary Disease
January 21, 2020A meta-analysis of RCTs
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Intensive Blood Pressure lowering and the Concerns about Falling
January 18, 2020The findings of SPRINT trial
-
Timing of Staged Non-Culprit Artery PCI in STEMI
January 7, 2020The findings of COMPLETE Trial about PCI timing
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
-
Inclisiran for patients with ASCVD and elevated LDL
December 2, 2019The findings of ORION-10 trial in ASCVD patients
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
Inclisiran in Heterozygous Familial Hypercholesterolemia (HeFH) and Elevated LDL
November 29, 2019The findings of ORION-9 trial about Inclisiran in HeFH
-
How to Select Appropriate Testing?
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
AF after Non-Cardiac Surgery Increases the Risk of Stroke
November 13, 2019A meta-analysis of post-operative AF studies
-
Rivaroxaban vs. Vit K Antagonist in Antiphospholipid Syndrome
November 12, 2019Rivaroxaban versus warfarin in APS
-
Antithrombotic treatment after CABG
November 12, 2019A recent meta-analysis on post-CABG Antithrombotic therapy
-
Triglyceride Lowering and Cardiovascular Risk Reduction
November 4, 2019A Systematic Review and Meta-Analysis of RCTs on TG lowering drugs
-
Guideline Made Easy
November 3, 2019Practical Guide for treatment of high blood cholesterol Part Three
-
Bedtime hypertension treatment improves cardiovascular risk reduction
October 29, 2019The findings of Hygia Chronotherapy Trial
-
Peri-operative beta-blockers in non-cardiac surgery
October 24, 2019The findings of Cochrane database systematic review
-
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease
October 15, 2019The findings of EXCEL Trial
-
Guideline Made Easy
October 3, 2019Practical Guide for treatment of high blood cholesterol Part Two
-
Pantoprazole in Patients Receiving Rivaroxaban and/or Aspirin
August 24, 2019The findings of COMPASS trial
-
OAC Monotherapy in Patients with Stable CAD and Non-valvular AF
August 20, 2019OACs in Stable CAD and AF
-
-
Optimal Timing of P2Y12 Inhibitor Loading in Patients Undergoing PCI
August 3, 2019P2Y12 loading dose timing in PCI
-
Lisinopril vs Carvedilol for Trastuzumab Cardiotoxicity in Breast Cancer
July 9, 2019Preventing the cardiotoxicity of Trastuzumab
-
Ezetimibe for the prevention of heart disease and death
June 14, 2019The role of Ezetimibe in reducing CVD adverse outcomes
-
Optimal Duration of Aspirin Plus Clopidogrel After Ischemic Stroke or TIA
May 25, 2019DAPT after ischemic stroke or TIA
-
-
-
Case Discussion (8)
July 12, 2017An ignored challenge in HTN management: Non-dippers An evidence-based discussion